Cited by 50Attention Deficit Hyperactivity DisorderNeuroethics, Human Enhancement, Biomedical InnovationsSubstance Abuse Treatment and Outcomes

Attention-Deficit/Hyperactivity Disorder in Adults: Evidence-Based Recommendations for Management

Rostain, Anthony L.·2008·Postgraduate Medicine

Abstract

Attention-deficit/hyperactivity disorder (ADHD) is associated with impairments in educational, occupational, neuropsychological, and social functioning in adults. Successful diagnosis and treatment of the disorder in adults can be a challenge because recent and integrative clinical guidelines are lacking and diagnostic criteria are based on making a retrospective diagnosis of childhood-onset ADHD. To develop evidence-based recommendations for the treatment of ADHD in adults, the scientific literature was reviewed, including primary clinical studies, meta-analyses, and available clinical guidelines. Studies show that stimulant therapy is highly effective and safe in the management of ADHD in adults, with similar response rates to those reported in children at doses that are equivalent on a mg/kg basis. Long-acting stimulants, such as OROS methylphenidate (OROS MPH, Concerta), dexmethylphenidate (d-MPH, Focalin), and mixed amphetamine salts extended release (MAS XR, Adderall XR), have durations of action of up to 10 to 12 hours, which permit once-daily dosing. For adults with ADHD who do not respond to stimulant therapy or who have a comorbid condition in which a stimulant is contraindicated, the nonstimulant atomoxetine (Strattera) may be an appropriate alternative. For many adults, cognitive-behavioral therapy in addition to pharmacotherapy may improve treatment response. Attention-deficit/hyperactivity disorder medications may increase blood pressure and heart rate in adults, so patients should be monitored.

Integrity signals

Registry

Crossref · 10.3810/pgm.2008.09.1905

Cites

72 of 72 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Rostain, A. L.
Affiliations
University of Pennsylvania (US)
Corresponding author
Rostain, Anthony L.
Venue
Postgraduate Medicine
Published
2008-01
Volume
120
Issue
3
Pages
27-38
ISSN
  • 0032-5481 (ISSN-L)
  • 1941-9260
OpenAlex
W2282858369
Cited by
50
References
72
Citations by year
2025: 2 · 2023: 1 · 2022: 1 · 2021: 3 · 2019: 2 · 2018: 3 · 2017: 3 · 2016: 1 · 2015: 4 · 2014: 6 · 2013: 5 · 2012: 9
FWCI
0.43
Type
journal article
Language
en
Open access
closed
Locations
  • Postgraduate Medicine (publishedVersion)
  • PubMed (publishedVersion)
Funders
Janssen Scientific Affairs
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Neuroethics, Human Enhancement, Biomedical Innovations
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
Keywords
adult ADHD, attention deficit hyperactivity disorder, stimulant medication, long-acting stimulants, OROS methylphenidate, dexmethylphenidate, atomoxetine, non-stimulant medication, cognitive behavioral therapy, comorbidities, treatment guidelines
MeSH terms
Adult, Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Humans, Cognitive Behavioral Therapy, Practice Guidelines as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review